| Dr Douglas Andrew Woelkers, MD | |
|
200 W Arbor Dr, Ucsd Medical Center, San Diego, CA 92103-8433 | |
| (619) 543-2384 | |
| (619) 543-3707 |
| Full Name | Dr Douglas Andrew Woelkers |
|---|---|
| Gender | Male |
| Speciality | Obstetrics/gynecology |
| Experience | 32 Years |
| Location | 200 W Arbor Dr, San Diego, California |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013965748 | NPI | - | NPPES |
| 00G771340 | Medicaid | CA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207VX0000X | Obstetrics & Gynecology - Obstetrics | G77134 (California) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Regents Of The University Of California | 3577476761 | 1692 |
News Archive
Two new studies presented today at the International Liver CongressTM 2014 have provided more evidence to clarify the role of non-alcoholic fatty liver disease (NAFLD) as an independent risk factor for the development of cardiovascular disease (CVD).
With about one month to go before the current exceptions process for clinically based care above the Medicare therapy caps expires, a majority of the U.S. House of Representatives has endorsed legislation to repeal the arbitrary financial limit on therapy benefits.
As part of the American Recovery and Reinvestment Act of 2009, the government is investing billions of dollars to encourage health care providers to use electronic health record systems. Many providers will probably switch from older systems to new systems to qualify for the federal incentives, but whether the upgrade improves patient care and safety has remained an open question.
Akorn, Inc. a niche generic pharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has granted approval of the Company's Erythromycin Ophthalmic Ointment USP 1 g as a supplement to the Company's already approved Abbreviated New Drug Application (ANDA) for Erythromycin Ophthalmic Ointment USP 3.5 g. The company has begun shipping the product to its customers.
An important new study has been launched by the University of Liverpool and Liverpool Women's Hospital (LWH), to test a new treatment for ‘retained placenta'- a condition where the placenta does not come out naturally after childbirth.
› Verified 2 days ago
| Entity Name | Regents Of The University Of California |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1326141862 PECOS PAC ID: 3577476761 Enrollment ID: O20031209001111 |
News Archive
Two new studies presented today at the International Liver CongressTM 2014 have provided more evidence to clarify the role of non-alcoholic fatty liver disease (NAFLD) as an independent risk factor for the development of cardiovascular disease (CVD).
With about one month to go before the current exceptions process for clinically based care above the Medicare therapy caps expires, a majority of the U.S. House of Representatives has endorsed legislation to repeal the arbitrary financial limit on therapy benefits.
As part of the American Recovery and Reinvestment Act of 2009, the government is investing billions of dollars to encourage health care providers to use electronic health record systems. Many providers will probably switch from older systems to new systems to qualify for the federal incentives, but whether the upgrade improves patient care and safety has remained an open question.
Akorn, Inc. a niche generic pharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has granted approval of the Company's Erythromycin Ophthalmic Ointment USP 1 g as a supplement to the Company's already approved Abbreviated New Drug Application (ANDA) for Erythromycin Ophthalmic Ointment USP 3.5 g. The company has begun shipping the product to its customers.
An important new study has been launched by the University of Liverpool and Liverpool Women's Hospital (LWH), to test a new treatment for ‘retained placenta'- a condition where the placenta does not come out naturally after childbirth.
› Verified 2 days ago
| Entity Name | Eisenhower Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1013981554 PECOS PAC ID: 5890689657 Enrollment ID: O20100506000102 |
News Archive
Two new studies presented today at the International Liver CongressTM 2014 have provided more evidence to clarify the role of non-alcoholic fatty liver disease (NAFLD) as an independent risk factor for the development of cardiovascular disease (CVD).
With about one month to go before the current exceptions process for clinically based care above the Medicare therapy caps expires, a majority of the U.S. House of Representatives has endorsed legislation to repeal the arbitrary financial limit on therapy benefits.
As part of the American Recovery and Reinvestment Act of 2009, the government is investing billions of dollars to encourage health care providers to use electronic health record systems. Many providers will probably switch from older systems to new systems to qualify for the federal incentives, but whether the upgrade improves patient care and safety has remained an open question.
Akorn, Inc. a niche generic pharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has granted approval of the Company's Erythromycin Ophthalmic Ointment USP 1 g as a supplement to the Company's already approved Abbreviated New Drug Application (ANDA) for Erythromycin Ophthalmic Ointment USP 3.5 g. The company has begun shipping the product to its customers.
An important new study has been launched by the University of Liverpool and Liverpool Women's Hospital (LWH), to test a new treatment for ‘retained placenta'- a condition where the placenta does not come out naturally after childbirth.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Douglas Andrew Woelkers, MD Po Box 232410, San Diego, CA 92193-2410 Ph: () - | Dr Douglas Andrew Woelkers, MD 200 W Arbor Dr, Ucsd Medical Center, San Diego, CA 92103-8433 Ph: (619) 543-2384 |
News Archive
Two new studies presented today at the International Liver CongressTM 2014 have provided more evidence to clarify the role of non-alcoholic fatty liver disease (NAFLD) as an independent risk factor for the development of cardiovascular disease (CVD).
With about one month to go before the current exceptions process for clinically based care above the Medicare therapy caps expires, a majority of the U.S. House of Representatives has endorsed legislation to repeal the arbitrary financial limit on therapy benefits.
As part of the American Recovery and Reinvestment Act of 2009, the government is investing billions of dollars to encourage health care providers to use electronic health record systems. Many providers will probably switch from older systems to new systems to qualify for the federal incentives, but whether the upgrade improves patient care and safety has remained an open question.
Akorn, Inc. a niche generic pharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has granted approval of the Company's Erythromycin Ophthalmic Ointment USP 1 g as a supplement to the Company's already approved Abbreviated New Drug Application (ANDA) for Erythromycin Ophthalmic Ointment USP 3.5 g. The company has begun shipping the product to its customers.
An important new study has been launched by the University of Liverpool and Liverpool Women's Hospital (LWH), to test a new treatment for ‘retained placenta'- a condition where the placenta does not come out naturally after childbirth.
› Verified 2 days ago
Ann Marie Pena, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 4647 Zion Ave, San Diego, CA 92120 Phone: 619-528-5000 | |
Yu-kang Ying, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 1325 Pacific Hwy, Unit 3301, San Diego, CA 92101 Phone: 818-876-2420 | |
Valerie Vaale Gafori, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 9339 Genesee Ave, Ste 220, San Diego, CA 92121 Phone: 858-455-7520 Fax: 858-554-1312 | |
Erin Andrea Gross, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 200 W Arbor Dr, San Diego, CA 92103 Phone: 800-926-8273 | |
Dr. Erin Barcarse, Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 200 W Arbor Dr, Dept 8433, San Diego, CA 92103 Phone: 619-543-7878 | |
Anupam Garg, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 2918 Fifth Ave, Suite 100, San Diego, CA 92103 Phone: 619-688-0770 Fax: 619-688-0987 |